1-3 of 3
Ailin Guo, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Mutation In Bruton Tyrosine Kinase Confers Acquired Resistance To Ibrutinib (PCI-32765) In CLL

Richard R. Furman, MD, Shuhua Cheng, PhD, Pin Lu, MD, PhD, Menu Setty, Alexandar Perez, Ailin Guo, MD, PhD, Joelle Racchumi, BS, Jiao Ma, PhD, Morton Coleman, MD, Kabaleeswaran Venkataraman, PhD, Guozhou Xu, PhD, Wei Chen, PhD, Hao Wu, PhD, Betty Y. Chang, PhD, Christina Leslie, PhD, Y. Lynn Wang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4914.
https://doi.org/10.1182/blood.V122.21.4914.4914
Published: 2013
Journal Articles

Dual SYK/JAK Inhibition Has a Broader Anti-Tumor Activity In Both ABC and GCB Types Of Diffuse Large B Cell Lymphoma

Jiao Ma, PhD, Greg Coffey, PhD, Pin Lu, MD, PhD, Shuhua Cheng, PhD, Ailin Guo, MD, PhD, Anjali Pandey, PhD, Y. Lynn Wang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1833.
https://doi.org/10.1182/blood.V122.21.1833.1833
Published: 2013
Journal Articles

BTK Inhibition Targets in Vivo CLL Proliferation Through Its Effects On B-Cell Receptor Signaling Activity.

Y. Lynn Wang, MD, PhD, Shuhua Cheng, PhD, Jiao Ma, PhD, Ailin Guo, MD, PhD, Pin Lu, MD, PhD, John P. Leonard, MD, Morton Coleman, MD, Momo Liu, BS, Joseph J. Buggy, PhD, Richard R. Furman, MD
Journal: Blood
Blood (2012) 120 (21): 2903.
https://doi.org/10.1182/blood.V120.21.2903.2903
Published: 2012